Bictegravir/emtricitabine/tenofovir alafenamide in patients with genotypic NRTI resistance.
HIV medicine（2023）
摘要
B/F/TAF was effective in maintaining HIV VL suppression in patients with previously documented NRTI RAMs without integrase resistance.
更多查看译文
关键词
HIV resistance,bictegravir
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要